Page 21 - AN-2-3
P. 21

Advanced Neurology                                                       The role of gut in multiple sclerosis



            can restrain EAE symptoms in HLA class-II transgenic   Among them, butyrate increases cellular metabolism and
            model.  P. histicola restrains disease by the alteration of   improves the memory capacity of activated CD8  T cells .
                                                                                                     +
                                                                                                           [47]
            systemic immune responses, leading to a decrease in pro-  It is worth noting that SCFAs can move across the BBB
            inflammatory Th1 and Th17 cells as well as a rise in the   and there are functional SCFA receptors in the CNS [48,49] .
            frequencies of CD4 FoxP3  regulatory T cells, tolerogenic   It is also notable that some SCFA-producing bacteria,
                           +
                                 +
                                                                                                           [50]
            DC, and suppressive macrophage . These findings point   including  A. muciniphila,  Roseburia inulinivorans ,
                                       [43]
            to functional relationships between variations in certain   Butyricimonas , and Faecalibacterium prausnitzii , have
                                                                          [35]
                                                                                                       [51]
            gut bacteria and a change toward a pro-inflammatory   been characterized.
            T-cell profile that may amplify or sustain autoimmune   Acetate, propionate, and butyrate concentrations in
            responses, perhaps discovering a previously unidentified   feces and blood samples are lower in MS patients than in
            environmental factor to MS pathogenesis.           HCs, possibly pointing to a protective role for SCFAs in
            2.2.4. Other evidence                              MS [41,52-54] . Notably, compared to healthy people, secondary
                                                               progressive MS patients had lower blood levels of acetate,
            Although immunological markers (such as Th2, Th17, and   propionate, and butyrate. The feces sample of RRMS
            Treg) did not change between cases and controls in research   patients likewise revealed identical findings, indicating
            of 24 kids (15 in relapsing remission and 9 in controls),   that these changes happen independently of the disease
            gut microbiota associations did. Species richness and   types [52,54] . Decreased  relative  abundance of  recognized
            Th17 showed a positive correlation for relapsing remission   SCFA-producers among the MS microbes, such as
            patients. Bacteroidetes had a negative correlation with   Roseburia, Coprococcus, Blautia, Faecalibacterium, Dorea,
            Th17 in relapsing remission patients, whereas Fusobacteria   Butyricicoccus, and  Clostridium  XIVb, is correlated with
            had a positive correlation with Tregs in control patients .   decreases in fecal SCFAs [41,55] .
                                                        [13]
            Another study that included 18 pediatric RRMS cases and   SCFAs have implications for MS disease. Serum caproic
            17 controls discovered that, in comparison to controls,   acid  (CA)  concentrations  increased  in  MS  patients  as
            MS cases had a significant depletion in  Lachnospiraceae   butyrate and acetate concentrations decreased. CA was
            and Ruminococcaceae as well as enrichment in members   also found to be positively associated with CD4 IFN-ɣ
                                                                                                       +
                                                                                                             +
            of the  Desulfovibrionaceae (Bilophila,  Desulfovibrio, and   T cells . Similarly, another study discovered that
                                                                     [41]
            Christensenellaceae). Microbial genes with expression   acetate concentration decreased in MS patients, which
            higher in MS than in control are involved in glutathione   was associated with a negative relationship with the pro-
            metabolism, and this result remains the same regardless   inflammatory biomarker IFN. In addition, it decreased
            of  the  administration  of  immunomodulatory  drugs .   the count of effector T cells in the intestine and increased
                                                        [9]
            Additional studies have shown that a lower abundance   the release of IL-10 by regulatory B cells, which improved
            of  butyrate-producing  microbes,  such  as  Butyricicoccus   EAE .
                                                                   [56]
            desmolans and Odoribacter, is linked to a higher risk of MS
            disease recurrence among children .                  Current studies on propionic acid confirm that
                                        [44]
                                                               it can improve the severity of MS. With propionate
            3. Microbial metabolites in the                    supplementation, the number of peripheral Tregs and
            pathogenesis of MS                                 their ability to inhibit MS symptoms ex vivo and in vitro
                                                               were found to increase with propionic acid in a way that
            3.1. SCFAs                                         was IL-10-dependent . Furthermore, Tregs treated
                                                                                 [53]
            With chain lengths ranging from one to six carbon   with propionate were transferred to EAE mice to lessen
            atoms, SCFAs are the primary component of dietary fiber   the severity of the illness. Last but not least, propionate
            fermentation in the colon. Butyrate, acetate, and propionate   also raises the quantity of Treg in the spleen and spinal
                                                                  [57]
            are the most common. SCFA helps to keep the intestinal   cord . According to these findings, propionate reduces
            barrier intact, and butyrate, in particular, improves   CNS autoimmunity by raising the number of Treg cells
            intestinal barrier function by regulating the expression of   throughout the body, including the CNS, where they are
            tight junction proteins . Intracellular butyrate, propionate,   likely to suppress continuing inflammation.
                             [45]
            and acetate inhibit histone deacetylases (HDACs) activity   Notably, Th17 cells treated with acetate exacerbated the
            and  promote histone  hyperacetylation; SCFAs appear to   EAE progression. As a result, this might tip the immune
            inhibit monocyte, macrophage, and DC maturation by   response in favor of a Th17 response . Surprisingly,
                                                                                                [52]
            suppressing HDACs, reduce pro-inflammatory cytokine   elevated levels of acetate were found in the plasma of MS
            production, and  promote  T cell differentiation  into   patients and were connected to higher numbers of CD8
                                                                                                             +
            Th1 cells, Th17 cells, IL-10  T cells, as well as Treg cells .   IL-17  T cells and greater neurological impairment . It was
                                                        [46]
                                 +
                                                                   +
                                                                                                      [58]
            Volume 2 Issue 3 (2023)                         4                          https://doi.org/10.36922/an.413
   16   17   18   19   20   21   22   23   24   25   26